Saturday, November 9, 2019
Sandia Preparatory School
532 Osuna Rd. NE
Albuquerque, NM

Contact Us 

Call: (505) 254-7784   
Visit: 2533 Virginia St NE, Suite C Albuquerque, NM 87110

2019 Fall Conference

The fall conference is scheduled for
November 9, 2019 from 9 a.m. to 2 p.m.
at Sandia Prepartory School in Albuquerque.


Join us for bi-weekly meetings that provide support and educational information.

Free Library & Resources

We have a library with helpful books and information in our office. We’re open Monday-Thursday from 10 a.m. to 2 p.m.

Approximately 1 in 7 men will get prostate cancer.

PCSANM's Position on US Preventative Services Task Force Revised Guideline on Prostate Cancer Screening

PCSANM applauds the newly-published guidelines of the USPSTF on prostate cancer screening for being a good start. There is much to be said for the fact that the task force paid attention to dissatisfaction with the prior 2012 guidelines. We also applaud the task force’s emphasis on the importance of shared and informed decision making in testing for prostate cancer.

However, while PCSANM is pleased with the “C” recommendation embodied in the guidelines, there are weaknesses and omissions. Why a “C” but only for men 55-69? Just because the retrospective studies to date have looked more at that age group than others ignores the fact that because prostate cancer is often slow-growing, one doesn’t see the benefits of screening sometimes for more than 10-15 years. Screening early means fewer chances of developing metastatic disease during those years, so why wait until 55 to start testing? We believe that a man’s first, baseline PSA should be around the age of 45, establishing risk and personalizing future follow up. That risk stratification is critical. PSA is just a data point; it is what you do with that information that is important. 

Why does the USPSTF (that worries about over treatment if a man is diagnosed) not recommend genomic testing, MRI, liquid biopsies, and other indolent disease that might lead to active surveillance rather than treatment? Why stop testing at age 70 and classify that as a “D” recommendation? Both the American Cancer Society and National Comprehensive Cancer Network talk about testing for men with at least a ten-year life expectancy– that should be the criterion, not an arbitrary age marker. And veterans, especially those who were exposed to Agent Orange, should be included in the “higher risk” population for earlier testing, along with African-American men and men with a positive family history.

US Preventative Services Task Force (USPSTF) Revised Guideline on Prostate Cancer Screening
For men ages 55 to 69 years, the decision to undergo periodic prostate-specific antigen (PSA)-based screening for prostate cancer should be an individual one. Before deciding whether to be screened, men should have an opportunity to discuss the potential benefits and harms of screening with their clinician and to incorporate their values and preferences in the decision. Screening offers a small potential benefit of reducing the chance of death from prostate cancer in some men. However, many men will experience potential harms of screening, including false-positive results that require additional testing and possible prostate biopsy; over diagnosis and over treatment; and treatment complications such as incontinence and erectile dysfunction. In determining whether this service is appropriate in individual cases, patients and clinicians should consider the balance of benefits and harms on the basis of family history, race/ethnicity, comorbid medical conditions, patient values about the benefits and harms of screening and treatment-specific outcomes, and other health needs. Clinicians should not screen men who do not express a preference for screening.
US Preventive Services Task Force "C" Grade for Prostate Cancer Testing
The USPSTF recommends selectively offering or providing this service to individual patients based on professional judgment and patient preferences. There is at least moderate certainty that the net benefit is small.

Offer or provide this service for selected patients depending on individual circumstances.

PCSANM helps all interested individuals and their families who are involved in coping with this disease.


We offer:

  • Publications and other reading materials on a wide variety of prostate cancer subjects
  • Free one-on-one consultations for those diagnosed with prostate cancer and those  dealing with the diagnosis of a loved one
  • A list of survivors willing to  discuss their treatment experience and side effects
  • Bi-monthly support meetings  including presentations by medical professionals expert in prostate cancer and related topics
  • Outreach activities at conferences and health fairs
  • Educational presentations  to organizations
  • Vouchers for free PSA tests for those who have no medical insurance, no primary care physician, or are experiencing troubling symptoms

We offer education, information, and support, but not medical advice.

Upcoming Events & Meetings

Would you like to support PCSANM?


PCSANM is a volunteer-run nonprofit organization and we could use your help. Choose a commitment level that suits you.
Contact us to learn more


Join us at events to help educate the public about prostate cancer.
Contact us to learn more


Help us unlock new possibilities in education and outreach for prostate cancer awareness.
How to Donate

No Registration form is selected.
(Click on the star on form card to select)
Please login to view this page.
Please login to view this page.
Please login to view this page.